tert-butyl (4R)-4-amino-3,3-difluoropiperidine-1-carboxylate, 250mg

2-(4-Bromophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane>98.0%(GC)1g

9-Amino-3-boc-3-azaspiro[5.5]undecane, 95.0%, 500mg

2-(2,4-Dioxopyrimidin-1-yl)-N-(2,2,2-trifluoroethyl)acetamide, 98%, 500mg

Copper(II) acetate monohydrate, 99.0%, 100g

N-Methyl-L-threonine, 97%, 1g

Methyl 3-[(dimethylamino)methyl]-5-fluorobenzoate hydrochloride, 95.0%, 250mg

Methyl 6-(aminomethyl)nicotinate hydrochloride, 95.0%, 100mg

2-Bromo-1-(3,4-dimethoxyphenyl)ethanone, 95.0%, 25g

3-HYDROXY-1-NAPHTHALDEHYDE, 97.0%, 100mg

TRANS-2-(TRIFLUOROMETHYL)CYCLOPROPANECARBOXYLIC ACID, 95.0%, 5g

2-Ethoxyethyl Methacrylate (stabilized with MEHQ)>98.0%(GC)25mL

tert-Butyl 3-(oxiran-2-yl)piperidine-1-carboxylate, 95%, 250mg